Clinical Trial Update: CAV Regimen Bridging to HSCT for R/R AL [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the CAV chemotherapy regimen as a bridge to hematopoietic stem cell transplantation in relapsed or refractory acute leukemia; study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• CYTARABINE (CYTARABINE)
• Vincristine (vincristine)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Leukemia, Relapsed, Acute Leukemia Refractory | Phase 2 | Status: COMPLETED